In CLL cells with dysfunctional TP53, DNA damage cannot induce cell cycle arrest or DNA repair, enabling the accumulation of substantial levels of DNA alterations that increase genomic instability and thereby lead to the emergence of subclones with additional genetic mutations that can drive CLL progression and transformation [98]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.